2013
DOI: 10.5489/cuaj.659
|View full text |Cite
|
Sign up to set email alerts
|

Identification of lymphatic pathway involved in the spreading of prostate cancer by fluorescence navigation approach with intraoperatively injected indocyanine green

Abstract: Objective: The objective of this study was to identify lymphatic vessels draining from the prostate by using a fluorescence navigation (FN) system. Methods: Fourteen subjects were candidates for radical retropubic prostatectomy (RRP) and pelvic lymph node dissection (PLND). After an indocyanine green solution was injected into the prostate during RRP, lymphatic vessels draining from the prostate were analyzed using a FN system. After PLND based on lymphatic mapping by the FN system (in vivo probing) was perfor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 11 publications
0
4
0
Order By: Relevance
“…Following the clinical approval of ICG for cutaneous Kaposi's sarcoma and cutaneous metastases of a rectal carcinoma they have been treated successfully [157159]. Crane et al have very recently used ICG in transcutaneous SLN detection in vulvar cancer patients [160] and Inoue et al for identification of lymphatic pathway involved in the spreading of prostate cancer [161]. …”
Section: Surgical Applicationsmentioning
confidence: 99%
“…Following the clinical approval of ICG for cutaneous Kaposi's sarcoma and cutaneous metastases of a rectal carcinoma they have been treated successfully [157159]. Crane et al have very recently used ICG in transcutaneous SLN detection in vulvar cancer patients [160] and Inoue et al for identification of lymphatic pathway involved in the spreading of prostate cancer [161]. …”
Section: Surgical Applicationsmentioning
confidence: 99%
“…The detection rate of the SN procedure ranged 76-100%. 5,8,9,12,23,25,29,31,33,36,[43][44][45][46][47][48] A total of 13-75% of the patients showed one or more SN outside the limited PLND template. In addition, SN were detected outside the standard PLND in 51.8-76.9% of the patients with positive LN.…”
Section: Clinical Implications Of Sn Biopsy For Pcamentioning
confidence: 99%
“…In 4.1-25% of patients, SN outside the ePLND template were found, whereas 3.5-17% of patients with positive LN had SN metastases outside the ePLND template. 5,7,8,[23][24][25]27,28,31,33,37,[43][44][45]47,[49][50][51][52][53][54] In these studies, the median percentage of positive LN was 20.4% (range 4.7-50) with a FN rate of 1% (range 0-20), respectively.…”
Section: Clinical Implications Of Sn Biopsy For Pcamentioning
confidence: 99%
See 1 more Smart Citation